Skip to main content
Signal8

Keson-Brookes Maiken

SEC insider (Form 3/4/5 filer). CIK 0001693805. Officer at Mural Oncology plc (MURA). 7 reported Form 4/5 transactions since Sep 2024; latest on Dec 5, 2025. Located in DUBLIN 2, L2.

Companies Keson-Brookes Maiken has filed insider reports for

  • Mural Oncology plc (MURA): Officer, See Remarks
Keson-Brookes Maiken profile photo

Keson-Brookes Maiken

CIK: 0001693805

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (71.4%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (14.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (14.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Mural Oncology plc logo
MURA

Mural Oncology plc

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Mural Oncology plc logo
    MURA

    Mural Oncology plc

    Dec 5, 2025
    Disposition
    Direct
    68.8K shares-
  • Mural Oncology plc logo
    MURA

    Mural Oncology plc

    Jul 22, 2025
    Sale
    Direct
    2.6K shares at avg. $2.48$6K
  • Mural Oncology plc logo
    MURA

    Mural Oncology plc

    Jul 18, 2025
    Sale
    Direct
    2.2K shares at avg. $2.48$5K
  • Mural Oncology plc logo
    MURA

    Mural Oncology plc

    Mar 5, 2025
    Sale
    Direct
    1.5K shares at avg. $3.45$5K
  • Mural Oncology plc logo
    MURA

    Mural Oncology plc

    Mar 4, 2025
    Sale
    Direct
    1.3K shares at avg. $3.36$4K
  • Mural Oncology plc logo
    MURA

    Mural Oncology plc

    Mar 3, 2025
    Award
    Direct
    35K shares-
  • Mural Oncology plc logo
    MURA

    Mural Oncology plc

    Dec 23, 2024
    Sale
    Direct
    2.6K shares at avg. $3.27$8K

1-7 of 7